Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2014 Feb;79(2):224-232.e1.
doi: 10.1016/j.gie.2013.08.002. Epub 2013 Sep 20.

Comparison of endoscopic therapies and surgical resection in patients with early esophageal cancer: a population-based study

Affiliations
Comparative Study

Comparison of endoscopic therapies and surgical resection in patients with early esophageal cancer: a population-based study

Sachin Wani et al. Gastrointest Endosc. 2014 Feb.

Abstract

Background: Outcome data comparing endoscopic eradication therapy (EET) and esophagectomy are limited in patients with early esophageal cancer (EC).

Objective: To compare overall survival and EC-related mortality in patients with early EC treated with EET and esophagectomy.

Design and setting: Population-based study.

Patients: Patients with early EC (stages T0 and T1) were identified from the Surveillance, Epidemiology, and End Results database (1998-2009). Demographics, tumor specific data, and survival were compared. Cox proportional hazards regression models were used to evaluate the association between treatment and EC-specific mortality.

Intervention: EET and esophagectomy.

Main outcome measurements: Mid- (2 years) and long- (5 years) term overall survival and EC-specific mortality, outcomes based on histology and stage, treatment patterns, and predictors of cancer-specific mortality.

Results: A total of 430 (21%) and 1586 (79%) patients underwent EET and esophagectomy, respectively. There was no difference in the 2-year (EET: 10.5% vs esophagectomy: 12.7%, P = .27).and 5-year (EET: 36.7% vs esophagectomy: 42.8%, P = .16) EC-related mortality rates between the 2 groups. EET patients had higher mortality rates attributed to non-EC causes (5 years: 46.6% vs 20.6%, P < .001). Similar results were noted when comparisons were limited to patients with stage T0 and T1a disease and esophageal adenocarcinoma. There was no difference in EC-specific mortality in the EET compared with the surgery group (hazard ratio 1.4; 95% confidence interval, 0.9-2.03). Variables associated with mortality were older age, year of diagnosis, radiation therapy, higher stage, and esophageal squamous cell carcinoma.

Limitations: Comorbidities and recurrence rates were not available.

Conclusions: This population-based study demonstrates comparable mid- and long-term EC-related mortality in patients with early EC undergoing EET and surgical resection.

Keywords: CI; EAC; EC; EET; ESCC; HR; SEER; Surveillance, Epidemiology, and End Results; confidence interval; endoscopic eradication therapy; esophageal adenocarcinoma; esophageal cancer; esophageal squamous cell carcinoma; hazard ratio.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Overall survival by the Kaplan-Meier’s estimate in endoscopic eradication therapies and esophagectomy groups
Figure 2
Figure 2
Proportion of esophageal cancer treated by endoscopic eradication therapies by stage and time

References

    1. Pohl H, Welch HG. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst. 2005;97:142–6. - PubMed
    1. Pohl H, Sirovich B, Welch HG. Esophageal adenocarcinoma incidence: are we reaching the peak? Cancer Epidemiol Biomarkers Prev. 2010;19:1468–70. - PubMed
    1. Peery AF, Dellon ES, Lund J, et al. Burden of gastrointestinal disease in the United States: 2012 update. Gastroenterology. 2012;143:1179–1187.e3. - PMC - PubMed
    1. Das A, Singh V, Fleischer DE, et al. A comparison of endoscopic treatment and surgery in early esophageal cancer: an analysis of surveillance epidemiology and end results data. Am J Gastroenterol. 2008;103:1340–5. - PubMed
    1. Rice TW, Rusch VW, Ishwaran H, et al. Cancer of the esophagus and esophagogastric junction: data-driven staging for the seventh edition of the American Joint Committee on Cancer/International Union Against Cancer Cancer Staging Manuals. Cancer. 2010;116:3763–73. - PubMed

Publication types

MeSH terms